STOCK TITAN

[424B2] Inverse VIX Short-Term Futures ETNs due March 22, 2045 Prospectus Supplement

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
424B2
Rhea-AI Filing Summary

Quantum-Si Incorporated (Nasdaq: QSI) has entered into a registered direct offering to sell 18.2 million shares of Class A common stock at $1.67 per share and pre-funded warrants for up to 11.74 million additional shares at $1.6699 per warrant (exercise price $0.0001). Gross proceeds are expected to total $49.999 million; after the 6 % placement fee to A.G.P./Alliance Global Partners and estimated expenses, net proceeds are projected at $47.0 million.

Following the share issuance (and excluding warrant exercise), Class A shares outstanding will rise from 163.56 million to 181.76 million, increasing total diluted shares to 193.50 million if the pre-funded warrants are fully exercised. Net tangible book value would increase modestly from $1.35 to $1.38 per share, creating an immediate dilution of $0.29 for new investors versus the offering price.

Cash and marketable securities would expand from $232.6 million to $279.4 million, strengthening liquidity without adding debt. Management intends to deploy the funds for (i) continued product development—including the Proteus™ platform, (ii) commercialization and manufacturing scale-up of Platinum™ and Platinum Pro devices, (iii) research & development, and (iv) general corporate purposes such as working capital and cap-ex.

Key structural terms include: insider and officer 60-day lock-up, company 45-day lock-up, pre-funded warrants to mitigate 4.99 %/9.99 % ownership caps, and 20-vote-per-share Class B stock (controlled by founder Dr. Jonathan Rothberg) remaining unchanged. The raise represents roughly 28 % of current Class A float, delivering capital for growth but at the cost of near-term dilution and potential overhang from warrant exercises.

Quantum-Si Incorporated (Nasdaq: QSI) ha avviato un'offerta diretta registrata per la vendita di 18,2 milioni di azioni ordinarie di Classe A a 1,67 $ per azione e warrant pre-finanziati per un massimo di 11,74 milioni di azioni aggiuntive a 1,6699 $ per warrant (prezzo di esercizio 0,0001 $). I proventi lordi previsti ammontano a 49,999 milioni di $; dopo una commissione di collocamento del 6% a favore di A.G.P./Alliance Global Partners e le spese stimate, i proventi netti sono stimati intorno a 47,0 milioni di $.

Dopo l'emissione delle azioni (escludendo l'esercizio dei warrant), le azioni Classe A in circolazione aumenteranno da 163,56 milioni a 181,76 milioni, portando il totale delle azioni diluite a 193,50 milioni se i warrant pre-finanziati verranno esercitati completamente. Il valore contabile tangibile netto per azione aumenterebbe leggermente da 1,35 $ a 1,38 $, generando una diluizione immediata di 0,29 $ per i nuovi investitori rispetto al prezzo dell'offerta.

La liquidità, inclusi titoli negoziabili, passerebbe da 232,6 milioni di $ a 279,4 milioni di $, rafforzando la posizione finanziaria senza aumentare l'indebitamento. La direzione intende utilizzare i fondi per (i) lo sviluppo continuo del prodotto, incluso la piattaforma Proteus™, (ii) la commercializzazione e l'espansione produttiva dei dispositivi Platinum™ e Platinum Pro, (iii) attività di ricerca e sviluppo, e (iv) scopi aziendali generali quali capitale circolante e investimenti in conto capitale.

I termini strutturali chiave comprendono: lock-up di 60 giorni per insider e dirigenti, lock-up di 45 giorni per la società, warrant pre-finanziati per mitigare i limiti di proprietà del 4,99%/9,99%, e azioni di Classe B con 20 voti per azione (controllate dal fondatore Dr. Jonathan Rothberg) che rimangono invariate. L'aumento rappresenta circa il 28% del flottante attuale di Classe A, fornendo capitale per la crescita ma con un costo di diluizione a breve termine e potenziale pressione derivante dall'esercizio dei warrant.

Quantum-Si Incorporated (Nasdaq: QSI) ha iniciado una oferta directa registrada para vender 18,2 millones de acciones comunes Clase A a $1.67 por acción y warrants prefinanciados para hasta 11,74 millones de acciones adicionales a $1.6699 por warrant (precio de ejercicio $0.0001). Se esperan ingresos brutos totales de $49.999 millones; tras la comisión de colocación del 6% a A.G.P./Alliance Global Partners y los gastos estimados, los ingresos netos se proyectan en $47.0 millones.

Después de la emisión de acciones (excluyendo el ejercicio de warrants), las acciones Clase A en circulación aumentarán de 163,56 millones a 181,76 millones, elevando el total de acciones diluidas a 193,50 millones si los warrants prefinanciados se ejercen completamente. El valor contable tangible neto por acción aumentaría modestamente de $1.35 a $1.38, generando una dilución inmediata de $0.29 para los nuevos inversores en comparación con el precio de la oferta.

El efectivo y valores negociables aumentarían de $232.6 millones a $279.4 millones, fortaleciendo la liquidez sin añadir deuda. La administración planea utilizar los fondos para (i) el desarrollo continuo del producto, incluyendo la plataforma Proteus™, (ii) la comercialización y escalado de fabricación de los dispositivos Platinum™ y Platinum Pro, (iii) investigación y desarrollo, y (iv) fines corporativos generales como capital de trabajo y gastos de capital.

Los términos estructurales clave incluyen: período de bloqueo de 60 días para insiders y ejecutivos, bloqueo de 45 días para la compañía, warrants prefinanciados para mitigar los límites de propiedad del 4.99%/9.99%, y acciones Clase B con 20 votos por acción (controladas por el fundador Dr. Jonathan Rothberg) que permanecen sin cambios. La recaudación representa aproximadamente el 28% del flotante actual de Clase A, proporcionando capital para el crecimiento pero a costa de dilución a corto plazo y posible presión por el ejercicio de warrants.

Quantum-Si Incorporated (나스닥: QSI)는 등록 직접 공모를 통해 클래스 A 보통주 1,820만 주를 주당 1.67달러에, 그리고 행사 가격이 0.0001달러인 프리펀드 워런트를 최대 1,174만 주까지 워런트당 1.6699달러에 판매하기로 했습니다. 총 예상 총수익은 4,999만 달러이며, A.G.P./Alliance Global Partners에 지급되는 6% 배치 수수료와 예상 비용을 제외한 순수익은 약 4,700만 달러로 예상됩니다.

주식 발행 후(워런트 행사 제외) 클래스 A 주식 수는 1억 6,356만 주에서 1억 8,176만 주로 증가하며, 프리펀드 워런트가 모두 행사될 경우 희석 주식 총수는 1억 9,350만 주에 달할 것입니다. 순유형자산 장부가치는 주당 1.35달러에서 1.38달러로 소폭 증가하며, 신규 투자자에게는 공모가 대비 0.29달러의 즉각적인 희석 효과가 발생합니다.

현금 및 시장성 증권은 2억 3,260만 달러에서 2억 7,940만 달러로 늘어나 부채 없이 유동성이 강화됩니다. 경영진은 자금을 (i) Proteus™ 플랫폼을 포함한 제품 개발 지속, (ii) Platinum™ 및 Platinum Pro 장치의 상용화 및 생산 확대, (iii) 연구개발, (iv) 운전자본 및 자본적 지출 등 일반 기업 목적에 사용할 계획입니다.

주요 구조적 조건으로는 내부자 및 임원 60일 락업, 회사 45일 락업, 4.99%/9.99% 소유 제한 완화를 위한 프리펀드 워런트, 그리고 창립자 Dr. Jonathan Rothberg가 통제하는 주당 20표의 클래스 B 주식이 변함없이 유지되는 점이 포함됩니다. 이번 자금 조달은 현재 클래스 A 유동 주식의 약 28%에 해당하며, 성장을 위한 자본을 제공하지만 단기 희석 및 워런트 행사로 인한 잠재적 부담이 따릅니다.

Quantum-Si Incorporated (Nasdaq : QSI) a lancé une offre directe enregistrée visant à vendre 18,2 millions d’actions ordinaires de Classe A au prix de 1,67 $ par action ainsi que des bons de souscription préfinancés pour jusqu’à 11,74 millions d’actions supplémentaires au prix de 1,6699 $ par bon (prix d’exercice 0,0001 $). Les produits bruts attendus s’élèvent à 49,999 millions de $ ; après une commission de placement de 6 % versée à A.G.P./Alliance Global Partners et les frais estimés, les produits nets sont projetés à 47,0 millions de $.

Après l’émission des actions (hors exercice des bons), le nombre d’actions de Classe A en circulation passera de 163,56 millions à 181,76 millions, portant le total des actions diluées à 193,50 millions si les bons préfinancés sont entièrement exercés. La valeur comptable tangible nette par action augmenterait légèrement de 1,35 $ à 1,38 $, entraînant une dilution immédiate de 0,29 $ pour les nouveaux investisseurs par rapport au prix de l’offre.

La trésorerie et les titres négociables augmenteraient de 232,6 millions $ à 279,4 millions $, renforçant la liquidité sans accroître l’endettement. La direction prévoit d’utiliser les fonds pour (i) poursuivre le développement des produits, y compris la plateforme Proteus™, (ii) la commercialisation et l’augmentation de la production des dispositifs Platinum™ et Platinum Pro, (iii) la recherche et développement, et (iv) des objectifs généraux d’entreprise tels que le fonds de roulement et les dépenses d’investissement.

Les principales conditions structurelles comprennent : une période de blocage de 60 jours pour les initiés et dirigeants, une période de blocage de 45 jours pour la société, des bons préfinancés pour atténuer les plafonds de propriété de 4,99 %/9,99 %, et des actions de Classe B avec 20 voix par action (contrôlées par le fondateur Dr Jonathan Rothberg) qui restent inchangées. Cette levée de fonds représente environ 28 % du flottant actuel de Classe A, apportant des capitaux pour la croissance mais au prix d’une dilution à court terme et d’une possible pression liée à l’exercice des bons.

Quantum-Si Incorporated (Nasdaq: QSI) hat eine registrierte Direktplatzierung gestartet, um 18,2 Millionen Aktien der Klasse A zum Preis von 1,67 $ pro Aktie sowie vorfinanzierte Warrants für bis zu 11,74 Millionen zusätzliche Aktien zu 1,6699 $ pro Warrant (Ausübungspreis 0,0001 $) zu verkaufen. Die Bruttoerlöse werden voraussichtlich 49,999 Millionen $ betragen; nach einer Platzierungsgebühr von 6 % an A.G.P./Alliance Global Partners und geschätzten Ausgaben werden die Nettoerlöse auf 47,0 Millionen $ geschätzt.

Nach der Aktienausgabe (ohne die Ausübung der Warrants) steigt die Anzahl der ausstehenden Klasse-A-Aktien von 163,56 Millionen auf 181,76 Millionen und die insgesamt verwässerten Aktien auf 193,50 Millionen, falls die vorfinanzierten Warrants vollständig ausgeübt werden. Der Netto-Buchwert je Aktie würde leicht von 1,35 $ auf 1,38 $ steigen, was für neue Investoren eine sofortige Verwässerung von 0,29 $ gegenüber dem Angebotspreis bedeutet.

Bargeld und marktfähige Wertpapiere würden sich von 232,6 Millionen $ auf 279,4 Millionen $ erhöhen, wodurch die Liquidität gestärkt wird, ohne Schulden aufzunehmen. Das Management plant, die Mittel für (i) die weitere Produktentwicklung – einschließlich der Proteus™-Plattform, (ii) die Kommerzialisierung und Produktionssteigerung der Platinum™- und Platinum Pro-Geräte, (iii) Forschung und Entwicklung sowie (iv) allgemeine Unternehmenszwecke wie Betriebskapital und Investitionen zu verwenden.

Wichtige strukturelle Bedingungen umfassen: 60-tägige Sperrfrist für Insider und Führungskräfte, 45-tägige Sperrfrist für das Unternehmen, vorfinanzierte Warrants zur Minderung der Eigentumsgrenzen von 4,99 %/9,99 % sowie unveränderte Klasse-B-Aktien mit 20 Stimmen pro Aktie (kontrolliert vom Gründer Dr. Jonathan Rothberg). Die Kapitalerhöhung entspricht etwa 28 % des aktuellen Streubesitzes der Klasse A und stellt Kapital für Wachstum bereit, verursacht jedoch kurzfristige Verwässerung und potenzielle Belastungen durch die Ausübung der Warrants.

Positive
  • $47 million in net proceeds meaningfully strengthens liquidity without increasing debt obligations.
  • Capital earmarked for Proteus™ platform and broader commercial rollout could accelerate revenue inflection.
  • Cash balance rises to $279 million, providing multi-year operating runway.
  • Transaction structured as registered direct—reduces market risk and expedites funding.
Negative
  • Issuance adds 18 %–28 % dilution to existing Class A shareholders depending on warrant exercise.
  • Offering price is 22 % below the prior closing price, indicating weak demand.
  • Pre-funded warrants create a potential overhang and future selling pressure.
  • Short lock-up periods (60/45 days) limit post-deal supply constraints.
  • 6 % placement fee (~$3 M) increases transaction cost relative to at-the-market alternatives.

Insights

TL;DR – $47 M cash bolsters runway but ~18 % dilution and warrant overhang temper equity upside.

The transaction increases cash reserves to ~$279 M, extending funding horizon for at least two years of R&D and commercial rollout. With no incremental debt, leverage remains low. However, issuing stock 22 % below the prior-day close ($2.14) and adding 28 % more Class A shares signals limited institutional demand and pressures EPS. Pre-funded warrants introduce potential selling pressure once exercised. Short lock-ups (60/45 days) could free additional shares before catalyst data arrives. Overall impact is moderately negative for existing shareholders but credit-positive for liquidity.

TL;DR – Fresh capital secures proteomics platform roadmap; execution on Proteus™ now critical.

Quantum-Si’s pipeline—Platinum™, Platinum Pro, and forthcoming Proteus™—requires heavy investment in reagent manufacturing, software, and global sales support. The $47 M raise, added to $233 M cash, should comfortably cover multi-year development cycles and instrument placements. Competitive landscape (Seer, Nautilus, Bruker MS) is heating; timely commercialization is vital. Investors should watch shipment volumes, consumable pull-through, and gross-margin trajectory as funds are deployed. If management converts cash into recurring consumables revenue, dilution will be offset by faster scaling.

Quantum-Si Incorporated (Nasdaq: QSI) ha avviato un'offerta diretta registrata per la vendita di 18,2 milioni di azioni ordinarie di Classe A a 1,67 $ per azione e warrant pre-finanziati per un massimo di 11,74 milioni di azioni aggiuntive a 1,6699 $ per warrant (prezzo di esercizio 0,0001 $). I proventi lordi previsti ammontano a 49,999 milioni di $; dopo una commissione di collocamento del 6% a favore di A.G.P./Alliance Global Partners e le spese stimate, i proventi netti sono stimati intorno a 47,0 milioni di $.

Dopo l'emissione delle azioni (escludendo l'esercizio dei warrant), le azioni Classe A in circolazione aumenteranno da 163,56 milioni a 181,76 milioni, portando il totale delle azioni diluite a 193,50 milioni se i warrant pre-finanziati verranno esercitati completamente. Il valore contabile tangibile netto per azione aumenterebbe leggermente da 1,35 $ a 1,38 $, generando una diluizione immediata di 0,29 $ per i nuovi investitori rispetto al prezzo dell'offerta.

La liquidità, inclusi titoli negoziabili, passerebbe da 232,6 milioni di $ a 279,4 milioni di $, rafforzando la posizione finanziaria senza aumentare l'indebitamento. La direzione intende utilizzare i fondi per (i) lo sviluppo continuo del prodotto, incluso la piattaforma Proteus™, (ii) la commercializzazione e l'espansione produttiva dei dispositivi Platinum™ e Platinum Pro, (iii) attività di ricerca e sviluppo, e (iv) scopi aziendali generali quali capitale circolante e investimenti in conto capitale.

I termini strutturali chiave comprendono: lock-up di 60 giorni per insider e dirigenti, lock-up di 45 giorni per la società, warrant pre-finanziati per mitigare i limiti di proprietà del 4,99%/9,99%, e azioni di Classe B con 20 voti per azione (controllate dal fondatore Dr. Jonathan Rothberg) che rimangono invariate. L'aumento rappresenta circa il 28% del flottante attuale di Classe A, fornendo capitale per la crescita ma con un costo di diluizione a breve termine e potenziale pressione derivante dall'esercizio dei warrant.

Quantum-Si Incorporated (Nasdaq: QSI) ha iniciado una oferta directa registrada para vender 18,2 millones de acciones comunes Clase A a $1.67 por acción y warrants prefinanciados para hasta 11,74 millones de acciones adicionales a $1.6699 por warrant (precio de ejercicio $0.0001). Se esperan ingresos brutos totales de $49.999 millones; tras la comisión de colocación del 6% a A.G.P./Alliance Global Partners y los gastos estimados, los ingresos netos se proyectan en $47.0 millones.

Después de la emisión de acciones (excluyendo el ejercicio de warrants), las acciones Clase A en circulación aumentarán de 163,56 millones a 181,76 millones, elevando el total de acciones diluidas a 193,50 millones si los warrants prefinanciados se ejercen completamente. El valor contable tangible neto por acción aumentaría modestamente de $1.35 a $1.38, generando una dilución inmediata de $0.29 para los nuevos inversores en comparación con el precio de la oferta.

El efectivo y valores negociables aumentarían de $232.6 millones a $279.4 millones, fortaleciendo la liquidez sin añadir deuda. La administración planea utilizar los fondos para (i) el desarrollo continuo del producto, incluyendo la plataforma Proteus™, (ii) la comercialización y escalado de fabricación de los dispositivos Platinum™ y Platinum Pro, (iii) investigación y desarrollo, y (iv) fines corporativos generales como capital de trabajo y gastos de capital.

Los términos estructurales clave incluyen: período de bloqueo de 60 días para insiders y ejecutivos, bloqueo de 45 días para la compañía, warrants prefinanciados para mitigar los límites de propiedad del 4.99%/9.99%, y acciones Clase B con 20 votos por acción (controladas por el fundador Dr. Jonathan Rothberg) que permanecen sin cambios. La recaudación representa aproximadamente el 28% del flotante actual de Clase A, proporcionando capital para el crecimiento pero a costa de dilución a corto plazo y posible presión por el ejercicio de warrants.

Quantum-Si Incorporated (나스닥: QSI)는 등록 직접 공모를 통해 클래스 A 보통주 1,820만 주를 주당 1.67달러에, 그리고 행사 가격이 0.0001달러인 프리펀드 워런트를 최대 1,174만 주까지 워런트당 1.6699달러에 판매하기로 했습니다. 총 예상 총수익은 4,999만 달러이며, A.G.P./Alliance Global Partners에 지급되는 6% 배치 수수료와 예상 비용을 제외한 순수익은 약 4,700만 달러로 예상됩니다.

주식 발행 후(워런트 행사 제외) 클래스 A 주식 수는 1억 6,356만 주에서 1억 8,176만 주로 증가하며, 프리펀드 워런트가 모두 행사될 경우 희석 주식 총수는 1억 9,350만 주에 달할 것입니다. 순유형자산 장부가치는 주당 1.35달러에서 1.38달러로 소폭 증가하며, 신규 투자자에게는 공모가 대비 0.29달러의 즉각적인 희석 효과가 발생합니다.

현금 및 시장성 증권은 2억 3,260만 달러에서 2억 7,940만 달러로 늘어나 부채 없이 유동성이 강화됩니다. 경영진은 자금을 (i) Proteus™ 플랫폼을 포함한 제품 개발 지속, (ii) Platinum™ 및 Platinum Pro 장치의 상용화 및 생산 확대, (iii) 연구개발, (iv) 운전자본 및 자본적 지출 등 일반 기업 목적에 사용할 계획입니다.

주요 구조적 조건으로는 내부자 및 임원 60일 락업, 회사 45일 락업, 4.99%/9.99% 소유 제한 완화를 위한 프리펀드 워런트, 그리고 창립자 Dr. Jonathan Rothberg가 통제하는 주당 20표의 클래스 B 주식이 변함없이 유지되는 점이 포함됩니다. 이번 자금 조달은 현재 클래스 A 유동 주식의 약 28%에 해당하며, 성장을 위한 자본을 제공하지만 단기 희석 및 워런트 행사로 인한 잠재적 부담이 따릅니다.

Quantum-Si Incorporated (Nasdaq : QSI) a lancé une offre directe enregistrée visant à vendre 18,2 millions d’actions ordinaires de Classe A au prix de 1,67 $ par action ainsi que des bons de souscription préfinancés pour jusqu’à 11,74 millions d’actions supplémentaires au prix de 1,6699 $ par bon (prix d’exercice 0,0001 $). Les produits bruts attendus s’élèvent à 49,999 millions de $ ; après une commission de placement de 6 % versée à A.G.P./Alliance Global Partners et les frais estimés, les produits nets sont projetés à 47,0 millions de $.

Après l’émission des actions (hors exercice des bons), le nombre d’actions de Classe A en circulation passera de 163,56 millions à 181,76 millions, portant le total des actions diluées à 193,50 millions si les bons préfinancés sont entièrement exercés. La valeur comptable tangible nette par action augmenterait légèrement de 1,35 $ à 1,38 $, entraînant une dilution immédiate de 0,29 $ pour les nouveaux investisseurs par rapport au prix de l’offre.

La trésorerie et les titres négociables augmenteraient de 232,6 millions $ à 279,4 millions $, renforçant la liquidité sans accroître l’endettement. La direction prévoit d’utiliser les fonds pour (i) poursuivre le développement des produits, y compris la plateforme Proteus™, (ii) la commercialisation et l’augmentation de la production des dispositifs Platinum™ et Platinum Pro, (iii) la recherche et développement, et (iv) des objectifs généraux d’entreprise tels que le fonds de roulement et les dépenses d’investissement.

Les principales conditions structurelles comprennent : une période de blocage de 60 jours pour les initiés et dirigeants, une période de blocage de 45 jours pour la société, des bons préfinancés pour atténuer les plafonds de propriété de 4,99 %/9,99 %, et des actions de Classe B avec 20 voix par action (contrôlées par le fondateur Dr Jonathan Rothberg) qui restent inchangées. Cette levée de fonds représente environ 28 % du flottant actuel de Classe A, apportant des capitaux pour la croissance mais au prix d’une dilution à court terme et d’une possible pression liée à l’exercice des bons.

Quantum-Si Incorporated (Nasdaq: QSI) hat eine registrierte Direktplatzierung gestartet, um 18,2 Millionen Aktien der Klasse A zum Preis von 1,67 $ pro Aktie sowie vorfinanzierte Warrants für bis zu 11,74 Millionen zusätzliche Aktien zu 1,6699 $ pro Warrant (Ausübungspreis 0,0001 $) zu verkaufen. Die Bruttoerlöse werden voraussichtlich 49,999 Millionen $ betragen; nach einer Platzierungsgebühr von 6 % an A.G.P./Alliance Global Partners und geschätzten Ausgaben werden die Nettoerlöse auf 47,0 Millionen $ geschätzt.

Nach der Aktienausgabe (ohne die Ausübung der Warrants) steigt die Anzahl der ausstehenden Klasse-A-Aktien von 163,56 Millionen auf 181,76 Millionen und die insgesamt verwässerten Aktien auf 193,50 Millionen, falls die vorfinanzierten Warrants vollständig ausgeübt werden. Der Netto-Buchwert je Aktie würde leicht von 1,35 $ auf 1,38 $ steigen, was für neue Investoren eine sofortige Verwässerung von 0,29 $ gegenüber dem Angebotspreis bedeutet.

Bargeld und marktfähige Wertpapiere würden sich von 232,6 Millionen $ auf 279,4 Millionen $ erhöhen, wodurch die Liquidität gestärkt wird, ohne Schulden aufzunehmen. Das Management plant, die Mittel für (i) die weitere Produktentwicklung – einschließlich der Proteus™-Plattform, (ii) die Kommerzialisierung und Produktionssteigerung der Platinum™- und Platinum Pro-Geräte, (iii) Forschung und Entwicklung sowie (iv) allgemeine Unternehmenszwecke wie Betriebskapital und Investitionen zu verwenden.

Wichtige strukturelle Bedingungen umfassen: 60-tägige Sperrfrist für Insider und Führungskräfte, 45-tägige Sperrfrist für das Unternehmen, vorfinanzierte Warrants zur Minderung der Eigentumsgrenzen von 4,99 %/9,99 % sowie unveränderte Klasse-B-Aktien mit 20 Stimmen pro Aktie (kontrolliert vom Gründer Dr. Jonathan Rothberg). Die Kapitalerhöhung entspricht etwa 28 % des aktuellen Streubesitzes der Klasse A und stellt Kapital für Wachstum bereit, verursacht jedoch kurzfristige Verwässerung und potenzielle Belastungen durch die Ausübung der Warrants.

 

JPMorgan Chase Financial Company LLC  July 2025

Pricing Supplement

Registration Statement Nos. 333-270004 and 333-270004-01

Dated July 2, 2025

Filed pursuant to Rule 424(b)(2)

Structured Investments

Opportunities in International Equities

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Principal at Risk Securities

Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.

 

The Dual Directional Trigger Jump Securities will pay no interest and do not guarantee any return of your principal at maturity. At maturity, you will receive for each security that you hold an amount in cash that will vary depending on the performance of the underlying index, as determined on the valuation date. If the final index value is greater than or equal to the initial index value, investors will receive at maturity, for each security, a fixed cash payment equal to the upside payment in addition to the stated principal amount. If the final index value is less than the initial index value but by no more than 10%, investors will receive at maturity the stated principal amount of the securities plus an unleveraged positive return equal to the absolute value of the percentage decline, which will effectively be limited to a positive 10% return. However, if the underlying index has depreciated by more than 10% in value, at maturity investors will lose the benefit of the absolute return feature and will lose 1% of the stated principal amount for every 1% of decline in the value of the underlying index over the term of the securities. The securities are for investors who seek an equity index-based return and who are willing to risk their principal and forgo current income in exchange for the upside payment and absolute return features that in each case apply to a limited range of the performance of the underlying index. The securities are unsecured and unsubordinated obligations of JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan Financial, the payment on which is fully and unconditionally guaranteed by JPMorgan Chase & Co., issued as part of JPMorgan Financial’s Medium-Term Notes, Series A, program. Any payment on the securities is subject to the credit risk of JPMorgan Financial, as issuer of the securities, and the credit risk of JPMorgan Chase & Co., as guarantor of the securities. The investor may lose a significant portion or all of the stated principal amount of the securities.

FINAL TERMS

Issuer:

JPMorgan Chase Financial Company LLC, a direct, wholly owned finance subsidiary of JPMorgan Chase & Co.

Guarantor:

JPMorgan Chase & Co.

Underlying index:

EURO STOXX 50® Index (Bloomberg ticker: SX5E Index)

Aggregate principal amount:

$11,872,000

Payment at maturity:

If the final index value is greater than or equal to the initial index value, for each $1,000 stated principal amount security:

 

$1,000 + upside payment

 

If the final index value is less than the initial index value but is greater than or equal to the trigger level, for each $1,000 stated principal amount security:

 

$1,000 + ($1,000 × absolute index return)

 

In this scenario, you will receive a 1% positive return on the securities for each 1% negative return on the underlying index. In no event will this amount exceed the stated principal amount plus $100.00. Accordingly, the maximum downside payment at maturity is $1,100.00 per security.

 

If the final index value is less than the trigger level, for each $1,000 stated principal amount security:

 

$1,000 × index performance factor

 

This amount will be less than the stated principal amount of $1,000 per security and will represent a loss of more than 10%, and possibly all, of your investment.

Upside payment:

$176.50 per $1,000 stated principal amount security (17.65% of the stated principal amount)

Index percent change:

(final index value – initial index value) / initial index value

Absolute index return:

The absolute value of the index percent change. For example, a -5% index percent change will result in a +5% absolute index return.

Initial index value:

The closing level of the underlying index on the pricing date, which was 5,318.72

Final index value:

The closing level of the underlying index on the valuation date

Trigger level:

4,786.848, which is 90% of the initial index value

Index performance factor:

final index value / initial index value

Stated principal amount:

$1,000 per security

Issue price:

$1,000 per security (see “Commissions and issue price” below)

Pricing date:

July 2, 2025

Original issue date (settlement date):

July 8, 2025

Valuation date*:

January 4, 2027

Maturity date*:

January 7, 2027

CUSIP / ISIN:

48136E4P7 / US48136E4P71

Listing:

The securities will not be listed on any securities exchange.

Agent:

J.P. Morgan Securities LLC (“JPMS”)

Commissions and issue price:

Price to public(1)

Fees and commissions

Proceeds to issuer

Per security

$1,000.00

$20.00(2)

$975.00

 

 

$5.00(3)

 

Total

$11,872,000.00

$296,800.00

$11,575,200.00

(1) See “Additional Information about the Securities — Supplemental use of proceeds and hedging” in this document for information about the components of the price to public of the securities.

(2) JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $20.00 per $1,000 stated principal amount security it receives from us to Morgan Stanley Smith Barney LLC (“Morgan Stanley Wealth Management”) See “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

(3) Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $5.00 for each $1,000 stated principal amount security

* Subject to postponement in the event of a market disruption event and as described under “General Terms of Notes — Postponement of a Determination Date — Notes Linked to a Single Underlying — Notes Linked to a Single Underlying (Other Than a Commodity Index)” and “General Terms of Notes — Postponement of a Payment Date” in the accompanying product supplement or early acceleration in the event of a change-in-law event as described under “General Terms of Notes — Consequences of a Change-in-Law Event” in the accompanying product supplement and “Risk Factors — Risks Relating to the Securities Generally — We may accelerate your securities in our sole discretion and the calculation agent may adjust their final payment in good faith and in a commercially reasonable manner if a change-in-law event occurs” in this document

The estimated value of the securities on the pricing date was $967.80 per $1,000 stated principal amount security. See “Additional Information about the Securities — The estimated value of the securities” in this document for additional information.

Investing in the securities involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk Factors” beginning on page PS-11 of the accompanying product supplement and “Risk Factors” beginning on page 6 of this document.

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the securities or passed upon the accuracy or the adequacy of this document or the accompanying product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense.

The securities are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank.

You should read this document together with the related product supplement, underlying supplement, prospectus supplement, prospectus and prospectus addendum, each of which can be accessed via the hyperlinks below. Please also see “Additional Information about the Securities” at the end of this document.

Product supplement no. 4-I dated April 13, 2023: http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf

Underlying supplement no. 1-I dated April 13, 2023: http://www.sec.gov/Archives/edgar/data/19617/000121390023029543/ea151873_424b2.pdf

Prospectus supplement and prospectus, each dated April 13, 2023: http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf

Prospectus addendum dated June 3, 2024: http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm

 

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

Investment Summary

Dual Directional Trigger Jump Securities

Principal at Risk Securities

The Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027 can be used:

As an alternative to direct exposure to the underlying index that provides a fixed, positive return of 17.65% (as reflected in the upside payment of $176.50 per $1,000 stated principal amount security) if the final index value is greater than or equal to the initial index value.

To enhance returns and potentially outperform the underlying index in a moderately bullish scenario.

To provide an unleveraged positive return in the event of a decline of the underlying index but only if the final index value is greater than or equal to the trigger level.

If the final index value is less than the trigger level, the securities are exposed on a 1-to-1 basis to any percentage decline of the final index value from the initial index value. Accordingly, investors may lose their entire initial investment in the securities.

 

Maturity:

Approximately 18 months

Upside payment:

$176.50 per $1,000 stated principal amount security (17.65% of the stated principal amount)

Trigger level:

90% of the initial index value

Minimum payment at maturity:

None. Investors may lose their entire initial investment in the securities.

Supplemental Terms of the Securities

For purposes of the accompanying product supplement, the underlying index is an “Index.”

Any values of the underlying index, and any values derived therefrom, included in this document may be corrected, in the event of manifest error or inconsistency, by amendment of this document and the corresponding terms of the securities. Notwithstanding anything to the contrary in the indenture governing the securities, that amendment will become effective without consent of the holders of the securities or any other party.

 

July 2025 Page 2

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

Key Investment Rationale

The securities offer a fixed, positive return if the underlying asset is flat or has appreciated on the valuation date as compared to its value on the pricing date and provides the opportunity, through the absolute return feature, to earn a positive return at maturity for a limited range of negative performance of the underlying asset. At maturity, if the underlying asset is flat or has appreciated, investors will receive the stated principal amount of their investment plus the upside payment. At maturity, if the underlying asset has depreciated in value but by no more than 10%, investors will receive the stated principal amount of their investment plus an unleveraged positive return equal to the absolute value of the percentage decline in the underlying asset, which will effectively be limited to a positive 10% return. However, at maturity, if the underlying asset has depreciated in value by more than 10%, investors will lose the benefit of the absolute return feature and will lose 1% of the stated principal amount for every 1% of decline, without any buffer. Investors may lose a significant portion or all of the stated principal amount of the securities.

Absolute Return Feature

The securities offer investors an opportunity to earn an unleveraged positive return if the final index value is less than the initial index value but is greater than or equal to the trigger level.

Upside Scenario

The final index value is greater than or equal to the initial index value and, at maturity, the payment at maturity for each security will be equal to $1,000.00 plus the upside payment of $176.50 per $1,000 stated principal amount security. Investors will not participate in any appreciation of the underlying index above 17.65%.

Absolute Return Scenario

The final index value is less than the initial index value but is greater than or equal to the trigger level, which is 90% of the initial index value. In this case, the securities pay a 1% positive return for each 1% negative return of the underlying index. For example, if the final index value is 5% less than the initial index value, the securities will provide a total positive return of 5% at maturity. The maximum return you may receive in this scenario is a positive 10% return at maturity.

Downside Scenario

The final index value is less than the trigger level. In this case, the securities pay an amount that is over 10% less than the stated principal amount and this decrease will be by an amount that is proportionate to the percentage decline in the final index value from the initial index value. (Example: if the underlying index decreases in value by 30%, the securities will pay an amount that is less than the stated principal amount by 30%, or $700 per security.)

July 2025 Page 3

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

How the Dual Directional Trigger Jump Securities Work

Payoff Diagram

The payoff diagram below illustrates the payment at maturity on the securities based on the following terms:

Stated principal amount:

$1,000 per $1,000 stated principal amount security

Upside payment:

$176.50 (17.65% of the stated principal amount) per $1,000 stated principal amount security

Trigger level:

90% of the initial index value

 

Dual Directional Trigger Jump Securities Payoff Diagram

 

How it works

Upside Scenario. If the final index value is greater than or equal to the initial index value, the payment at maturity in all cases is equal to and will not exceed the $1,000 stated principal amount plus the upside payment. Under the terms of the securities, in the payoff diagram, an investor will receive the payment at maturity of $1,176.50 per security if the final index percent change is greater than or equal to the initial index value.

Absolute Return Scenario. If the final index value is less than the initial index value but is greater than or equal to the trigger level, investors will receive a 1% positive return on the securities for each 1% negative return of the underlying index.

For example, if the underlying index depreciates 5%, investors will receive a 5% return, or $1,050 per $1,000 stated principal amount security.

The maximum return you may receive in this scenario is a positive 10% return at maturity.

Downside Scenario. If the final index value is less than the trigger level, investors will lose the benefit of the absolute return feature and will instead receive an amount that is significantly less than the stated principal amount by an amount proportionate to the percentage decrease of the final index value from the initial index value. This amount will be less than 90% of the stated principal amount per security.

For example, if the underlying index depreciates 50%, investors will lose 50% of their principal and receive only $500 per $1,000 stated principal amount security at maturity, or 50% of the stated principal amount.

The hypothetical returns and hypothetical payments on the securities shown above apply only if you hold the securities for their entire term. These hypotheticals do not reflect fees or expenses that would be associated

July 2025 Page 4

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and hypothetical payments shown above would likely be lower.

July 2025 Page 5

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

Risk Factors

The following is a non-exhaustive list of certain key risk factors for investors in the securities. For further discussion of these and other risks, you should read the sections entitled “Risk Factors” of the accompanying prospectus supplement and the accompanying product supplement and Annex A to the accompanying prospectus addendum. We urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.

Risks Relating to the Securities Generally

The securities do not pay interest or guarantee the return of any principal and your investment in the securities may result in a loss. The terms of the securities differ from those of ordinary debt securities in that the securities do not pay interest or guarantee the payment of any principal amount at maturity. If the final index value is less than the trigger level (which is 90% of the initial index value), you will lose the benefit of the absolute return feature and the payment at maturity will be an amount in cash that is over 10% less than the stated principal amount of each security, and this decrease will be by an amount that is proportionate to the decrease in the value of the underlying index and may be zero. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities.

Appreciation potential is fixed and limited if the underlying index appreciates or remains flat. If the final index value is greater than or equal to the initial index value, the appreciation potential of the securities is limited to the fixed upside payment of $176.50 per security (17.65% of the stated principal amount), even if the final index value is significantly greater than the initial index value. See “How the Dual Directional Trigger Jump Securities Work” above.

Your maximum downside gain on the securities is limited by the trigger level. If the final index value is less than the initial index value and greater than or equal to the trigger level, you will receive at maturity $1,000 plus a return equal to the absolute index return, which will reflect a 1% positive return for each 1% negative return on the underlying index, subject to an effective limit of 10%. Because you will not receive a positive return if the underlying index has depreciated below the trigger level, your maximum downside payment will be $1,100.00 per $1,000.00 stated principal amount security.

The securities are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co., and any actual or anticipated changes to our or JPMorgan Chase & Co.’s credit ratings or credit spreads may adversely affect the market value of the securities. Investors are dependent on our and JPMorgan Chase & Co.’s ability to pay all amounts due on the securities. Any actual or anticipated decline in our or JPMorgan Chase & Co.’s credit ratings or increase in our or JPMorgan Chase & Co.’s credit spreads determined by the market for taking that credit risk is likely to adversely affect the market value of the securities. If we and JPMorgan Chase & Co. were to default on our payment obligations, you may not receive any amounts owed to you under the securities and you could lose your entire investment.

As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets. As a finance subsidiary of JPMorgan Chase & Co., we have no independent operations beyond the issuance and administration of our securities and the collection of intercompany obligations. Aside from the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of JPMorgan Chase & Co. to make payments under loans made by us to JPMorgan Chase & Co. or under other intercompany agreements. As a result, we are dependent upon payments from JPMorgan Chase & Co. to meet our obligations under the securities. We are not a key operating subsidiary of JPMorgan Chase & Co. and in a bankruptcy or resolution of JPMorgan Chase & Co. we are not expected to have sufficient resources to meet our obligations in respect of the securities as they come due. If JPMorgan Chase & Co. does not make payments to us and we are unable to make payments on the securities, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that guarantee will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan Chase & Co. For more information, see the accompanying prospectus addendum.

The benefit provided by the trigger level may terminate on the valuation date. If the final index value is less than the trigger level, the benefit provided by the trigger level will terminate and you will be fully exposed to any depreciation of the underlying index.

Secondary trading may be limited. The securities will not be listed on a securities exchange. There may be little or no secondary market for the securities. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the securities easily. JPMS may act as a market maker for the securities, but is not required to do so. Because we do not expect that other market makers will participate significantly in the secondary market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any, at which JPMS is willing to buy the securities. If at any time JPMS or another agent does not act as a market maker, it is likely that there would be little or no secondary market for the securities.

We may accelerate your securities in our sole discretion and the calculation agent may adjust their final payment in good faith and in a commercially reasonable manner if a change-in-law event

July 2025 Page 6

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

occurs. Upon the announcement or occurrence of legal or regulatory changes that the calculation agent determines are likely to interfere with your or our ability to transact in or hold the securities or our ability to hedge or perform our obligations under the securities, we may, in our sole and absolute discretion, accelerate the payment on your securities and pay you an amount determined in good faith and in a commercially reasonable manner by the calculation agent.  If the payment on your securities is accelerated, your investment may result in a loss and you may not be able to reinvest your money in a comparable investment.  Please see “General Terms of Notes — Consequences of a Change-in-Law Event” in the accompanying product supplement for more information.

The tax consequences of an investment in the securities are uncertain. There is no direct legal authority as to the proper U.S. federal income tax characterization of the securities, and we do not intend to request a ruling from the IRS. The IRS might not accept, and a court might not uphold, the treatment of the securities described in “Additional Information about the Securities ― Additional Provisions ― Tax considerations” in this document and in “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement. If the IRS were successful in asserting an alternative treatment for the securities, the timing and character of any income or loss on the securities could differ materially and adversely from our description herein. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should review carefully the section entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement and consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by this notice.

Risks Relating to Conflicts of Interest

Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of the securities and other affiliates of the issuer may be different from those of investors. We and our affiliates play a variety of roles in connection with the issuance of the securities, including acting as calculation agent and as an agent of the offering of the securities, hedging our obligations under the securities and making the assumptions used to determine the pricing of the securities and the estimated value of the securities, which we refer to as the estimated value of the securities. In performing these duties, our and JPMorgan Chase & Co.’s economic interests and the economic interests of the calculation agent and other affiliates of ours are potentially adverse to your interests as an investor in the securities. The calculation agent has determined the initial index value and the trigger level, will determine the final index value and will calculate the amount of payment you will receive at maturity, if any. Determinations made by the calculation agent, including with respect to the occurrence or non-occurrence of market disruption events, the selection of a successor to the underlying index or calculation of the final index value in the event of a discontinuation or material change in method of calculation of the underlying index, may affect the payment to you at maturity.

In addition, our and JPMorgan Chase & Co.’s business activities, including hedging and trading activities, could cause our and JPMorgan Chase & Co.’s economic interests to be adverse to yours and could adversely affect any payment on the securities and the value of the securities. It is possible that hedging or trading activities of ours or our affiliates in connection with the securities could result in substantial returns for us or our affiliates while the value of the securities declines. Please refer to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying product supplement for additional information about these risks.

Hedging and trading activities by the issuer and its affiliates could potentially affect the value of the securities. The hedging or trading activities of the issuer’s affiliates and of any other hedging counterparty with respect to the securities on or prior to the pricing date and prior to maturity could have adversely affected, and may continue to adversely affect, the level of the underlying index and, as a result, could decrease the amount an investor may receive on the securities at maturity, if any. Any of these hedging or trading activities on or prior to the pricing date could have affected the initial index value and the trigger level and, therefore, could potentially increase the level that the final index value must reach before you receive a payment at maturity that exceeds the issue price of the securities or so that you do not suffer a loss on your initial investment in the securities. Additionally, these hedging or trading activities during the term of the securities, including on the valuation date, could adversely affect the final index value and, accordingly, the payment to you at maturity, if any. It is possible that these hedging or trading activities could result in substantial returns for us or our affiliates while the value of the securities declines.

Risks Relating to the Estimated Value and Secondary Market Prices of the Securities

July 2025 Page 7

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

The estimated value of the securities is lower than the original issue price (price to public) of the securities. The estimated value of the securities is only an estimate determined by reference to several factors. The original issue price of the securities exceeds the estimated value of the securities because costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These costs include the selling commissions, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities. See “Additional Information about the Securities — The estimated value of the securities” in this document.

The estimated value of the securities does not represent future values of the securities and may differ from others’ estimates. The estimated value of the securities is determined by reference to internal pricing models of our affiliates. This estimated value of the securities is based on market conditions and other relevant factors existing at the time of pricing and assumptions about market parameters, which can include volatility, dividend rates, interest rates and other factors. Different pricing models and assumptions could provide valuations for the securities that are greater than or less than the estimated value of the securities. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the securities could change significantly based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.’s creditworthiness, interest rate movements and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy securities from you in secondary market transactions. See “Additional Information about the Securities — The estimated value of the securities” in this document.

The estimated value of the securities is derived by reference to an internal funding rate. The internal funding rate used in the determination of the estimated value of the securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates.  Any difference may be based on, among other things, our and our affiliates’ view of the funding value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities. The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. See “Additional Information about the Securities — The estimated value of the securities” in this document.

The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than the then-current estimated value of the securities for a limited time period. We generally expect that some of the costs included in the original issue price of the securities will be partially paid back to you in connection with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period. These costs can include selling commissions, the structuring fee, projected hedging profits, if any, and, in some circumstances, estimated hedging costs and our internal secondary market funding rates for structured debt issuances. See “Additional Information about the Securities — Secondary market prices of the securities” in this document for additional information relating to this initial period. Accordingly, the estimated value of your securities during this initial period may be lower than the value of the securities as published by JPMS (and which may be shown on your customer account statements).

Secondary market prices of the securities will likely be lower than the original issue price of the securities. Any secondary market prices of the securities will likely be lower than the original issue price of the securities because, among other things, secondary market prices take into account our internal secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions, the structuring fee, projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the securities. As a result, the price, if any, at which JPMS will be willing to buy securities from you in secondary market transactions, if at all, is likely to be lower than the original issue price. Any sale by you prior to the maturity date could result in a substantial loss to you. See the immediately following risk factor for information about additional factors that will impact any secondary market prices of the securities.

The securities are not designed to be short-term trading instruments. Accordingly, you should be able and willing to hold your securities to maturity. See “— Risks Relating to the Securities Generally Secondary trading may be limited” above.

Secondary market prices of the securities will be impacted by many economic and market factors.  The secondary market price of the securities during their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the selling commissions, structuring fee, projected hedging profits, if any, estimated hedging costs and the closing level of the underlying index, including:

oany actual or potential change in our or JPMorgan Chase & Co.’s creditworthiness or credit spreads;

ocustomary bid-ask spreads for similarly sized trades;

July 2025 Page 8

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

oour internal secondary market funding rates for structured debt issuances;

othe actual and expected volatility of the underlying index;

othe time to maturity of the securities;

othe dividend rates on the equity securities included in the underlying index;

ointerest and yield rates in the market generally;

othe exchange rates and the volatility of the exchange rates between the U.S. dollar and each of the currencies in which the equity securities included in the underlying index trade and the correlation among those rates and the levels of the underlying index; and

oa variety of other economic, financial, political, regulatory and judicial events.

Additionally, independent pricing vendors and/or third party broker-dealers may publish a price for the securities, which may also be reflected on customer account statements. This price may be different (higher or lower) than the price of the securities, if any, at which JPMS may be willing to purchase your securities in the secondary market.

Risks Relating to the Underlying Index

Investing in the securities is not equivalent to investing in the underlying index. Investing in the securities is not equivalent to investing in the underlying index or its component stocks. Investors in the securities will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to the stocks that constitute the underlying index.

Adjustments to the underlying index could adversely affect the value of the securities. The underlying index publisher may discontinue or suspend calculation or publication of the underlying index at any time. In these circumstances, the calculation agent will have the sole discretion to substitute a successor index that is comparable to the discontinued underlying index and is not precluded from considering indices that are calculated and published by the calculation agent or any of its affiliates.

The securities are subject to risks associated with securities issued by non-U.S. companies. The equity securities included in the underlying index have been issued by non-U.S. companies. Investments in securities linked to the value of such non-U.S. equity securities involve risks associated with the home countries and/or the securities markets in the home countries of the issuers of those non-U.S. equity securities, including risks of volatility in those markets, governmental intervention in those markets and cross shareholdings in companies in certain countries. Also, there is generally less publicly available information about companies in some of these jurisdictions than there is about U.S. companies that are subject to the reporting requirements of the SEC, and generally non-U.S. companies are subject to accounting, auditing and financial reporting standards and requirements and securities trading rules different from those applicable to U.S. reporting companies.

The securities are not directly exposed to fluctuations in foreign exchange rates. The value of your securities will not be adjusted for exchange rate fluctuations between the U.S. dollar and the currencies upon which the equity securities included in the underlying index are based, although any currency fluctuations could affect the performance of the underlying index. Therefore, if the applicable currencies appreciate or depreciate relative to the U.S. dollar over the term of the securities, you will not receive any additional payment or incur any reduction in any payment on the securities.

Governmental legislative and regulatory actions, including sanctions, could adversely affect your investment in the securities.  Governmental legislative and regulatory actions, including, without limitation, sanctions-related actions by the U.S. or a foreign government, could prohibit or otherwise restrict persons from holding the securities or the securities included in the underlying index, or engaging in transactions in them, and any such action could adversely affect the value of the securities or the underlying index.  These legislative and regulatory actions could result in restrictions on the securities.  You may lose a significant portion or all of your initial investment in the securities if you are forced to divest the securities due to the government mandates, especially if such divestment must be made at a time when the value of the securities has declined.

July 2025 Page 9

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

EURO STOXX 50® Index Overview

The EURO STOXX 50® Index consists of 50 component stocks of market sector leaders from within the Eurozone. For additional information about the EURO STOXX 50® Index, see “Equity Index Descriptions ― The STOXX Benchmark Indices” in the accompanying underlying supplement.

Information as of market close on July 2, 2025:

Bloomberg Ticker Symbol:

SX5E

52 Week High (on 3/3/2025):

5,540.69

Current Closing Level:

5,318.72

52 Week Low (on 8/5/2024):

4,571.60

52 Weeks Ago (on 7/2/2024):

4,906.33

 

 

The following table sets forth the published high and low closing levels, as well as end-of-quarter closing levels, of the underlying index for each quarter in the period from January 1, 2020 through July 2, 2025. The associated graph shows the closing levels of the underlying index for each day in the same period. The closing level of the underlying index on July 2, 2025 was 5,318.72. We obtained the closing level information above and in the table and graph below from the Bloomberg Professional® service (“Bloomberg”), without independent verification. The historical closing levels of the underlying index should not be taken as an indication of future performance, and no assurance can be given as to the closing level of the underlying index on the valuation date. The payment of dividends on the stocks that constitute the underlying index are not reflected in its closing level and, therefore, have no effect on the calculation of the payment at maturity.

EURO STOXX 50® Index

High

Low

Period End

2020

 

 

 

First Quarter

3,865.18

2,385.82

2,786.90

Second Quarter

3,384.29

2,662.99

3,234.07

Third Quarter

3,405.35

3,137.06

3,193.61

Fourth Quarter

3,581.37

2,958.21

3,552.64

2021

 

 

 

First Quarter

3,926.20

3,481.44

3,919.21

Second Quarter

4,158.14

3,924.80

4,064.30

Third Quarter

4,246.13

3,928.53

4,048.08

Fourth Quarter

4,401.49

3,996.41

4,298.41

2022

 

 

 

First Quarter

4,392.15

3,505.29

3,902.52

Second Quarter

3,951.12

3,427.91

3,454.86

Third Quarter

3,805.22

3,279.04

3,318.20

Fourth Quarter

3,986.83

3,331.53

3,793.62

2023

 

 

 

First Quarter

4,315.05

3,856.09

4,315.05

Second Quarter

4,408.59

4,218.04

4,399.09

Third Quarter

4,471.31

4,129.18

4,174.66

Fourth Quarter

4,549.44

4,014.36

4,521.44

2024

 

 

 

First Quarter

5,083.42

4,403.08

5,083.42

Second Quarter

5,100.90

4,839.14

4,894.02

Third Quarter

5,067.45

4,571.60

5,000.45

Fourth Quarter

5,041.01

4,729.71

4,895.98

July 2025 Page 10

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the EURO STOXX 50® Index due January 7, 2027

Trigger Performance Leveraged Upside SecuritiesSM

Principal at Risk Securities

EURO STOXX 50® Index

High

Low

Period End

2025

 

 

 

First Quarter

5,540.69

4,871.45

5,248.39

Second Quarter

5,454.65

4,622.14

5,297.07

Third Quarter (through July 2, 2025)

5,318.72

5,282.43

5,318.72

 

EURO STOXX 50® Index Historical Performance – Daily Closing Levels*

January 2, 2020 to July 2, 2025

*The dotted line in the graph indicates the trigger level, equal to 90% of the initial index value.

License Agreement. The EURO STOXX 50® Index and STOXX® are the intellectual property (including registered trademarks) of STOXX Limited, Zurich, Switzerland and/or its licensors (the “Licensors”), which are used under license. The securities based on the EURO STOXX 50® Index are in no way sponsored, endorsed, sold or promoted by STOXX Limited and its Licensors and neither Stoxx Limited nor any of its Licensors shall have any liability with respect thereto. See “Equity Index Descriptions — The STOXX Benchmark Indices — License Agreement” in the accompanying underlying supplement.

July 2025 Page 11

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the S&P 500® Index due September 6, 2029

Principal at Risk Securities

 

Additional Information about the Securities

Please read this information in conjunction with the terms on the front cover of this document.

Additional Provisions:

Postponement of maturity date:

If the scheduled maturity date is not a business day, then the maturity date will be the following business day. If the scheduled valuation date is not a trading day or if a market disruption event occurs on that day so that the valuation date is postponed and falls less than three business days prior to the scheduled maturity date, the maturity date of the securities will be postponed to the third business day following the valuation date as postponed.

Minimum ticketing size:

$1,000 / 1 security

Trustee:

Deutsche Bank Trust Company Americas (formerly Bankers Trust Company)

Calculation agent:

JPMS

The estimated value of the securities:

The estimated value of the securities set forth on the cover of this document is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component with the same maturity as the securities, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying the economic terms of the securities. The estimated value of the securities does not represent a minimum price at which JPMS would be willing to buy your securities in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated value of the securities may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’ view of the funding value of the securities as well as the higher issuance, operational and ongoing liability management costs of the securities in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing market replacement funding rate for the securities.  The use of an internal funding rate and any potential changes to that rate may have an adverse effect on the terms of the securities and any secondary market prices of the securities. For additional information, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is derived by reference to an internal funding rate” in this document. The value of the derivative or derivatives underlying the economic terms of the securities is derived from internal pricing models of our affiliates. These models are dependent on inputs such as the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments. Accordingly, the estimated value of the securities on the pricing date is based on market conditions and other relevant factors and assumptions existing at that time. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities does not represent future values of the securities and may differ from others’ estimates” in this document.

The estimated value of the securities is lower than the original issue price of the securities because costs associated with selling, structuring and hedging the securities are included in the original issue price of the securities. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the structuring fee, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities and the estimated cost of hedging our obligations under the securities. Because hedging our obligations entails risk and may be influenced by market forces beyond our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. A portion of the profits, if any, realized in hedging our obligations under the securities may be allowed to other affiliated or unaffiliated dealers, and we or one or more of our affiliates will retain any remaining hedging profits. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The estimated value of the securities is lower than the original issue price (price to public) of the securities” in this document.

Secondary market prices of the securities:

For information about factors that will impact any secondary market prices of the securities, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — Secondary market prices of the securities will be impacted by many economic and market factors” in this document. In addition, we generally expect that some

July 2025 Page 12

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the S&P 500® Index due September 6, 2029

Principal at Risk Securities

of the costs included in the original issue price of the securities will be partially paid back to you in connection with any repurchases of your securities by JPMS in an amount that will decline to zero over an initial predetermined period that is intended to be the shorter of two years and one-half of the stated term of the securities. The length of any such initial period reflects the structure of the securities, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs of hedging the securities and when these costs are incurred, as determined by our affiliates. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Securities — The value of the securities as published by JPMS (and which may be reflected on customer account statements) may be higher than the then-current estimated value of the securities for a limited time period.”

Tax considerations:

You should review carefully the section entitled “Material U.S. Federal Income Tax Consequences” in the accompanying product supplement no. 4-I. The following discussion, when read in combination with that section, constitutes the full opinion of our special tax counsel, Davis Polk & Wardwell LLP, regarding the material U.S. federal income tax consequences of owning and disposing of the securities.

Based on current market conditions, in the opinion of our special tax counsel, it is reasonable to treat your securities as “open transactions” that are not debt instruments for U.S. federal income tax purposes, as more fully described in “Material U.S. Federal Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Open Transactions That Are Not Debt Instruments” in the accompanying product supplement. Assuming this treatment is respected, the gain or loss on your securities should be treated as long-term capital gain or loss if you hold your securities for more than a year, whether or not you are an initial purchaser of securities at the issue price. However, the IRS or a court may not respect this treatment of the securities, in which case the timing and character of any income or loss on the securities could be materially and adversely affected. In addition, in 2007 Treasury and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; the relevance of factors such as the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose a notional interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments and the issues presented by this notice.

Supplemental use of proceeds and hedging:

The securities are offered to meet investor demand for products that reflect the risk-return profile and market exposure provided by the securities. See “How the Dual Directional Trigger Jump Securities Work” in this document for an illustration of the risk-return profile of the securities and “EURO STOXX 50® Index Overview” in this document for a description of the market exposure provided by the securities.

The original issue price of the securities is equal to the estimated value of the securities plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, and the structuring fee, plus (minus) the projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the securities, plus the estimated cost of hedging our obligations under the securities.

July 2025 Page 13

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the S&P 500® Index due September 6, 2029

Principal at Risk Securities

Benefit plan investor considerations:

See “Benefit Plan Investor Considerations” in the accompanying product supplement.

Supplemental plan of distribution:

Subject to regulatory constraints, JPMS intends to use its reasonable efforts to offer to purchase the securities in the secondary market, but is not required to do so. JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions it receives from us to Morgan Stanley Wealth Management. In addition, Morgan Stanley Wealth Management will receive a structuring fee as set forth on the cover of this document for each security.

We or our affiliate may enter into swap agreements or related hedge transactions with one of our other affiliates or unaffiliated counterparties in connection with the sale of the securities and JPMS and/or an affiliate may earn additional income as a result of payments pursuant to the swap or related hedge transactions. See “— Supplemental use of proceeds and hedging” above and “Use of Proceeds and Hedging” in the accompanying product supplement.

Validity of the securities and the guarantee:

In the opinion of Davis Polk & Wardwell LLP, as special products counsel to JPMorgan Financial and JPMorgan Chase & Co., when the securities offered by this pricing supplement have been issued by JPMorgan Financial pursuant to the indenture, the trustee and/or paying agent has made, in accordance with the instructions from JPMorgan Financial, the appropriate entries or notations in its records relating to the master global note that represents such securities (the “master note”), and such securities have been delivered against payment as contemplated herein, such securities will be valid and binding obligations of JPMorgan Financial and the related guarantee will constitute a valid and binding obligation of JPMorgan Chase & Co., enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above or (ii) any provision of the indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of JPMorgan Chase & Co.’s obligation under the related guarantee. This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the indenture and its authentication of the master note and the validity, binding nature and enforceability of the indenture with respect to the trustee, all as stated in the letter of such counsel dated February 24, 2023, which was filed as an exhibit to the Registration Statement on Form S-3 by JPMorgan Financial and JPMorgan Chase & Co. on February 24, 2023.

July 2025 Page 14

JPMorgan Chase Financial Company LLC

Dual Directional Trigger Jump Securities Based on the Value of the S&P 500® Index due September 6, 2029

Principal at Risk Securities

Where you can find more information:

You should read this document together with the accompanying prospectus, as supplemented by the accompanying prospectus supplement, relating to our Series A medium-term notes of which these securities are a part, the accompanying prospectus addendum and the more detailed information contained in the accompanying product supplement and the accompanying underlying supplement.

This document, together with the documents listed below, contains the terms of the securities and supersedes all other prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, stand-alone fact sheets, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set forth in the “Risk Factors” sections of the accompanying prospectus supplement and the accompanying product supplement and in Annex A to the accompanying prospectus addendum, as the securities involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisers before you invest in the securities.

You may access these documents on the SEC website at www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):

Product supplement no. 4-I dated April 13, 2023:

http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf

• Underlying supplement no. 1-I dated April 13, 2023:

http://www.sec.gov/Archives/edgar/data/19617/000121390023029543/ea151873_424b2.pdf

• Prospectus supplement and prospectus, each dated April 13, 2023:

http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf

• Prospectus addendum dated June 3, 2024:

http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm

Our Central Index Key, or CIK, on the SEC website is 1665650, and JPMorgan Chase & Co.’s CIK is 19617.

As used in this document, “we,” “us,” and “our” refer to JPMorgan Financial.

 

July 2025 Page 15

FAQ

How much capital will Quantum-Si (QSI) raise in the July 2025 offering?

Gross proceeds are $49.999 million; net proceeds after fees and expenses are expected to be ~$47.0 million.

What will QSI use the new funds for?

Management plans to fund Proteus™ development, expand commercialization of Platinum™ instruments, support manufacturing scale-up, R&D, and general corporate purposes.

How much shareholder dilution results from the transaction?

Class A shares outstanding rise from 163.6 M to 181.8 M (or 193.5 M if pre-funded warrants are exercised), implying 18 %–28 % dilution.

What is the impact on Quantum-Si’s balance sheet?

Cash and marketable securities increase to $279.4 million, while long-term debt stays at $11.7 million, improving liquidity metrics.

When will the offering close and who is the placement agent?

Closing is expected on or about July 8, 2025; A.G.P./Alliance Global Partners is acting as sole placement agent for a 6 % fee.

Do the pre-funded warrants trade on Nasdaq?

No. The warrants are unlisted; there is no established public market for them.
Inverse VIX S/T Futs ETNs due Mar22,2045

NYSE:VYLD

VYLD Rankings

VYLD Latest News

VYLD Latest SEC Filings

VYLD Stock Data

4.00M
National Commercial Banks
NEW YORK